Clinical Trial Update: Effect of Dexmedetomidine on Perfusion Index and Microcirculation in Severe Sepsis and Septic Shock Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update examining dexmedetomidine effects on perfusion index and microcirculation in patients with septic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Cairo University | Conditions: Septic Shock | Phase 3 | Status: UNKNOWN